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The pacemaker properties of the suprachiasmatic
nucleus (SCN) circadian clock are shaped by mecha-
nisms that influence the expression and behavior of
clock proteins. Here, we reveal that G-protein-
coupled receptor kinase 2 (GRK2) modulates the
period, amplitude, and entrainment characteristics
of the SCN. Grk2-deficient mice show phase-depen-
dent alterations in light-induced entrainment, slower
recovery from jetlag, and longer behavioral rhythms.
Grk2 ablation perturbs intrinsic rhythmic properties
of the SCN, increasing amplitude and decreasing
period. At the cellular level, GRK2 suppresses the
transcription of the mPeriod1 gene and the traf-
ficking of PERIOD1 and PERIOD2 proteins to the nu-
cleus. Moreover, GRK2 can physically interact with
PERIOD1/2 and promote PERIOD2 phosphorylation
at Ser545, effects that may underlie its ability to regu-
late PERIOD1/2 trafficking. Together, our findings
identify GRK2 as an importantmodulator of circadian
clock speed, amplitude, and entrainment by control-
ling PERIOD at the transcriptional and post-transla-
tional levels.
INTRODUCTION
Circadian timekeeping mechanisms evolved to allow organisms
to anticipate and respond to cyclical changes in their environ-
ment (Reppert and Weaver, 2002). In mammals, the central
circadian pacemaker, the suprachiasmatic nucleus (SCN), dic-
tates the tempo of physiological and behavioral rhythms to
near-24-hr periodicity through generation and maintenance of
self-sustained rhythms, which in turn are synchronized to envi-
ronmental day-night cycles by the process of photic entrainment
(Moore, 2013). Themolecular basis of circadian rhythms involves
a set of core clock proteins that interact in a series of transcrip-1272 Cell Reports 12, 1272–1288, August 25, 2015 ª2015 The Authotion-translation feedback loops (TTFLs) to drive their own rhyth-
mic gene expression (Reppert andWeaver, 2002). Heterodimers
of CLOCK-BMAL1 transcription factors activate E-box-medi-
ated transcription of Period (Per) andCryptochrome (Cry) genes.
The subsequent translocation of PER and CRY proteins to the
nucleus closes the feedback loop by repressing CLOCK-
BMAL1-dependent transcription. Photic entrainment also relies
on transcriptional activation of period genes within the SCN
(Akiyama et al., 1999). However, beyond transcription, mecha-
nisms that control protein translation or post-translational mod-
ifications (e.g., phosphorylation) can likewise have profound
effects on core clock oscillations and entrainment (Gallego and
Virshup, 2007). Numerous studies have shown the importance
of specific protein kinases in the transcriptional, translational,
and post-translational control of the circadian clock (Gallego
and Virshup, 2007).
In our search to identify key players in SCN clock regulation,
we focused on G-protein-coupled receptor (GPCR) kinase 2
(GRK2). GRK2 belongs to a family of serine/threonine protein ki-
nases that directly phosphorylate agonist-bound GPCRs and
downregulate receptor-mediated signaling via receptor desensi-
tization and/or internalization (Gurevich et al., 2012). There are
seven mammalian GRKs: GRK1 through GRK7. Expression of
GRK1 and GRK7 is restricted primarily to rod and cone photore-
ceptors, whereas the remaining GRKs are expressed in the
rodent brain and in other tissues (Gurevich et al., 2012). In
smooth muscle, GRK2 has been shown to mediate the desensi-
tization of VPAC2 (Murthy et al., 2008), the receptor for vasoac-
tive intestinal peptide (VIP), a critical neuropeptide for SCN clock
function (Aton et al., 2005). Drosophila GRK2 has been shown to
underlie circadian rhythms in olfactory responses through GPCR
regulation in olfactory sensory neurons (Tanoue et al., 2008). In
addition to its classical function as a GPCR kinase, GRK2 can
phosphorylate non-GPCR substrates including various receptor
tyrosine kinases, structural proteins (e.g., tubulin), and intracel-
lular signaling proteins (Penela et al., 2010). GRK2 can also
regulate the function of receptors and other proteins in a
kinase-independent manner through direct physical associa-
tion (Penela et al., 2010). The combination of its classical andrs
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noncanonical functions prompted us to explore GRK20s poten-
tial contribution to the regulation of the murine SCN clock.
Here, we report that GRK2 is a modulator of circadian period,
amplitude, and entrainment, through its effects on mPer1 tran-
scription and nuclear trafficking of PER1 and PER2.
RESULTS
Genetic Disruption of GRK2 in Mice Lengthens the
Free-Running Behavioral Period and Alters Light-
Induced Entrainment
To begin our study, we examined the temporal expression of
GRK2 and other GRK family members within the murine SCN.
GRK2 protein was found to be both abundant and expressed
at constant levels throughout the circadian cycle (Figures S1A
and S1B). qPCR analyses revealed a lack of circadian fluctuation
of grk2 at the mRNA level and the expression of grk3, grk4, and
grk5 within the SCN (Figure S1C). Of the four, only grk3 and grk4
exhibited rhythmic expression at the mRNA level, both peaking
in the mid subjective night (Figure S1C). These results, however,
do not rule out the possibility that GRK2 activity/function fluctu-
ates in the SCN across the circadian cycle or in response to light,
as exemplified by extracellular signal-regulated kinases (ERKs)
1/2 (Obrietan et al., 1998).
To investigate the function of GRK2 in the central clock, we
employed two independent gene-targeted mouse models. The
first is a heterozygous grk2 (grk2+/) mouse strain generated
by conventional gene targeting (Jaber et al., 1996). The second
is a conditional ablation of the grk2 gene in GABAergic neurons
using a Vgat-IRES-Cre mouse strain (Vong et al., 2011) to drive
Cre-mediated excision of the grk2 floxed alleles (grk2fl/fl; Matko-
vich et al., 2006) in vesicular GABA transporter (VGAT)-express-
ing cells. Previous studies have shown that the majority of SCN
neurons are GABAergic (Moore, 2013). As expected, GRK2 pro-
tein levels in the SCNwere reduced by >50% in grk2+/mice and
were negligible in Vgat-driven grk2 conditional knockouts (grk2
cKO) (Figure S1D).
Next, we assessed the circadian behavior of grk2+/ and grk2
cKO mice using a spectrum of experimental lighting paradigms.
The phase angle (c) of entrainment under a fixed 12-hr light:12-hr
dark (LD) cycle was significantly delayed in grk2+/ and grk2 cKO
mice relative to grk2wild-type (WT) control mice (phase angle [h]:
WT, 0.03 ± 0.03 [n = 20]; grk2+/, 0.17 ± 0.04 [n = 14]; grk2 cKO,
0.20 ± 0.05 [n = 11]; p < 0.05 WT versus grk2+/; p < 0.01 WT
versus grk2 cKO). Consistent with the known dependence of c
on intrinsic circadian period, both mutant strains exhibited aFigure 1. Loss of GRK2 Lengthens Locomotor Activity Rhythms and A
(A, C, E, G, and I) Representative actograms of wheel-running activities of WT, gr
mice were released into DD (at red arrowhead). In (C), LD-entrained mice were r
15-min light pulse (LP; yellow dot) at (E) CT 15 or (G) CT 22. Regression lines (red) th
shifts. In (I), mice were entrained to a fixed LD cycle prior to an abrupt advance o
below each actogram indicate the original and 7-hr-advanced LD cycles, respec
(B and D) Period under (B) DD and (D) LL conditions.
(F and H) Phase shifts to a (F) CT 15 and (H) CT 22 LP.
(J) Days to re-entrain to a 7-hr advanced LD cycle.
(K) Daily phase shifts to a 7-hr advanced LD cycle.
All values represent mean ± SEM; n = 8 to 21mice per genotype. *p < 0.05, **p < 0
grk2+/ and grk2 cKO; ***p < 0.001 versus grk2 cKO; **p < 0.01 versus grk2+/ (f
1274 Cell Reports 12, 1272–1288, August 25, 2015 ª2015 The Authosignificantly longer free-running period under constant darkness
(DD) (Figures 1A and 1B). The circadian period under long-term
constant dim (10 lux) light (LL) was significantly longer in grk2
cKO mice compared with both WT and grk2+/ mice (Figures
1C and 1D). All animals remained rhythmic under dim LL for
the duration of the experiment. In terms of the acute effects of
light, a brief light pulse (15 min, 30 lux) in the early subjective
night (CT 15) produced larger phase delays in grk2+/ and grk2
cKO mice compared to WT controls (Figures 1E and 1F). Light-
induced phase advances (15 min, 40 lux) in the late night
(CT 22) were significantly attenuated in grk2 cKO, but not
grk2+/, mice relative to WT controls (Figures 1G and 1H). There
was no correlation between the period under DD and the magni-
tude of phase delays (Figure S1E) or phase advances (Fig-
ure S1F), suggesting that the longer period of grk2 mutant
mice does not contribute to their phase-shift phenotypes. In an
experimental jetlag paradigm, mice experienced an abrupt
advance of the LD cycle by 7 hr. Grk2+/ and grk2 cKO mice
took significantly longer to re-entrain to the new LD cycle relative
to WT controls (Figures 1I–1K). Grk2 ablation does not alter the
expression of grk3, grk4, or grk5 in the SCN (Figure S1G), ruling
out the possibility that the observed phenotypes are due to
compensatory changes in these other GRKs.
Collectively, our results show that loss of one or both copies of
grk2 slows behavioral rhythms under DD, augments light-
induced phase delays, and decelerates the rate of re-entrain-
ment to an advanced LD cycle. Deletion of both copies in
GABAergic neurons is required to significantly attenuate acute
photic phase advances and enhance period lengthening under
dim LL.
The Effects of GRK2 on the Molecular Clock in the SCN
The longer behavioral period under DD suggests that GRK2 may
influence the oscillatory properties of the core molecular clock
within the SCN. In the SCN of WT mice, PERIOD1 (PER1) and
PERIOD2 (PER2) protein abundance exhibited robust rhythms
that peaked in the early and mid-subjective night, respectively
(Figures 2A, 2B, 2F, 2G, and S2A–S2D). The amplitudes of
PER1 and PER2 oscillations were significantly augmented in
grk2 cKO mice (Figures 2A, 2B, 2F, and 2G) and grk2+/ mice
(Figures S2A–S2D) relative to WT control, due to increased
peak expression at the expected CT. Single-cell analysis of
PER immunoreactivity revealed that a greater number of SCN
cells expressed high nuclear levels of PER1 and PER2 at CT14
and CT18, respectively, in the grk2 cKO mice (Figures 2C and
2H) than in WT controls. Enhanced expression is visuallylters Entrainment to Light
k2+/, and grk2 cKO mice under different light conditions. In (A), LD-entrained
eleased into dim LL (10 lux) for 16 weeks. In (E and G), mice in DD received a
rough daily activity onsets before and after the LPwere used tomeasure phase
f the LD cycle by 7 hr (at blue arrowhead). Horizontal colored bars above and
tively.
.01, ***p < 0.001 versusWT (for B, D, F, H, and J). **p < 0.01, ***p < 0.001 versus
or K). See also Figure S1.
rs
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apparent in high-magnification images of the SCN immuno-
stained for PER1 (Figures 2D and 2E) and PER2 (Figures 2I and
2J). These effects were specific to PER1/2, as we observed no
change in BMAL1 protein expression in the SCN of grk2 cKO
mice across a 24-hr circadian cycle (Figures S2E and S2F).
To determine whether the circadian amplitude phenotype is
intrinsic to the SCN of grk2 cKO mice, we examined PER2::LUC
bioluminescence rhythms in SCN tissue explants harvested
from WT (grk2+/+), VGAT-cre::grk2+/fl (heterozygous for grk2 in
GABAergic neurons), and grk2 cKO (VGAT-cre::grk2fl/fl) mice
(Figure 2K). The amplitude was significantly greater in grk2
cKO SCN compared with the two control groups (Figures 2K,
2M, and S2H). Surprisingly, the period of PER2::LUC oscillations
was shortened in grk2 cKO SCN relative to WT and VGAT-
cre::grk2+/fl controls (Figures 2L and S2G). The rhythms damp-
ened at a comparable rate across all experimental groups
(Figures 2N and S2I). The shortened period of molecular rhythms
was also observed in PER2::LUC murine embryonic fibroblasts
(MEFs) upon small interfering RNA (siRNA)-mediated silencing
of grk2 (Figures 2O, 2P, and S2J). Collectively, our data show
that GRK2 suppresses the amplitude and lengthens the period
of molecular rhythms within the SCN.
The Effects of GRK2 on GPCR Internalization and
Expression in the SCN
To elucidate the potential mechanisms by which GRK2 regulates
the SCN clock, we first addressed the canonical function of
GRK2 in GPCR desensitization and internalization. To this end,
the trafficking of green/yellow fluorescent protein (GFP/YFP)-
tagged versions of VIP, AVP, and PACAP receptors (VPAC2,
V1b, and PAC1, respectively) were examined in Neuro2A or
HEK293 cells that co-expressed either WT GRK2 or a domi-
nant-negative kinase-deficient GRK2 (GRK2 K220R) (Kong
et al., 1994). Levels of ectopic GRK2 and GRK2 K220R were
similar in both cell lines (Figure S3A). Under basal (no ligand) con-
ditions, VPAC2 receptors were localized to the plasma mem-
brane and diffusely throughout the cytoplasm (Figure 3A),
whereas V1b and PAC1 receptors were found predominantly
at the plasma membrane (Figures 3C and 3D). In pcDNA3.1-
transfected control cells, stimulation with VIP or AVP triggered
robust internalization of VPAC2 (Figure 3A) and V1b (Figure 3C)
receptors, respectively, as indicated by a strong decrease inFigure 2. Loss of GRK2 Increases the Amplitude of PER1 and PER2 Pr
(A, D–F, I, and J) Representative micrographs of (A) PER1 and (F) PER2 immunore
(D and E) PER1 at CT 14 and (I and J) PER2 at CT 18 by (D and I) immunohisto
nuclear stain.
(B and G) Number of (B) PER1- and (G) PER2-IR nuclei in the SCN as a function
(C and H) Intensity distribution of (C) PER1 at CT 14 and (H) PER2 at CT 18 based
Low threshold values (on the x axis) indicate strong expression, whereas high thre
per genotype. *p < 0.05, **p < 0.01, ***p < 0.001 versus WT.
(K) mPER2::LUC bioluminescence traces from SCN explants from grk2 cKO mic
after second media change. Note the higher amplitude and shorter period in grk
(L–N) Histograms showing (L) period length, (M) amplitude, and (N) amplitude d
cre::grk2fl/+ (black), and grk2 cKO (red) SCN explants following the second medi
(O) Bioluminescence traces from mPER2::LUC MEFs that were transfected with
(P) Period length of NC or grk2 siRNA-transfected mPER2::LUC MEFs. n = 4 per
results.
*p < 0.05, **p < 0.01 versus WT and VGAT-cre::grk2fl/+ (L), versus VGAT-cre::grk
1276 Cell Reports 12, 1272–1288, August 25, 2015 ª2015 The Authoplasma membrane fluorescence and concurrent increase in
punctate cytoplasmic foci. GRK2 overexpression had no appre-
ciable effect on the basal distribution or ligand-triggered internal-
ization of VPAC2 and V1b receptors (Figures 3A and 3C),
suggesting that the activity of endogenousGRK2 (and potentially
other GRKs) is sufficient to mediate receptor trafficking. In
contrast, overexpression of GRK2 K220R, which competes
with endogenous GRK2 for the receptors and prevents their
phosphorylation, strongly attenuated VIP-induced VPAC2 inter-
nalization without altering basal distribution (Figure 3A). The
internalization of AVP-stimulated V1b receptors was less sensi-
tive to the ameliorating effects of GRK2 K220R (Figure 3C).
PAC1 receptors exhibited partial internalization in response to
PACAP stimulation, as evident by the increase in cytoplasmic
foci (Figure 3D). GRK2 K220R suppressed ligand-induced
PAC1 internalization, whereas overexpression of GRK2 had no
effect (Figure 3D). Importantly, siRNA-mediated knockdown of
endogenous GRK2 (Figure S3B) had no effect on basal distribu-
tion of VPAC2 receptors but attenuated VIP-induced receptor
internalization (Figure 3B), thus supporting a bona fide role of
GRK2 in VPAC2 trafficking. It should be noted that up to 1 hr
post-VIP stimulation, total VPAC2 levels were unaltered between
grk2 siRNA-transfected and negative control (NC) siRNA-trans-
fected cultures and between basal and post-stimulation time
points (Figure S3C).
Next, we examined the effects of grk2 ablation on the VIP-
VPAC2 system in the SCN. Time-of-day fluctuations in VPAC2
protein abundance in the SCN were markedly altered in
grk2 cKO mice (Figures 3E and 3F). Specifically, VPAC2 levels
were augmented in grk2 cKO SCN relative to WT at most time
points, reaching significance at CT 14 and CT 18 (Figures 3E
and 3F). Vpac2 transcript levels in the SCNwere comparable be-
tween WT and grk2 cKOmice, suggesting a post-transcriptional
effect of GRK2 on VPAC2 expression (Figure S3D). Despite the
lack of change in total VPAC2 levels in our cell culture model
up to 1h post-VIP stimulation, the temporal profile of VIP-
VPAC2 signaling in the SCN in vivo is likely to be quite different.
Given that prolonged exposure to VIP is required to induce
GRK2-dependent VPAC2 degradation (Murthy et al., 2008), the
most parsimonious explanation for altered VPAC2 abundance
in the grk2 cKO SCN is a reduction in internalization-coupled re-
ceptor degradation. The observed suppression in VIP levels inotein Rhythms in the SCN and Shortens Ex Vivo SCN Rhythms
activity (IR) in the SCN of WT and grk2 cKOmice. High-magnification images of
chemistry (IHC) and (E and J) indirect IF. DAPI (blue, E and J) was used as a
of CT. Threshold was set at 150 and 160 for PER1 and PER2, respectively.
on IHC staining. Cells that exceeded a given expression threshold are counted.
shold values indicate weak expression. All values represent mean ± SEM; n = 4
e (red) and VGAT-cre::grk2fl/+ controls (black). x axis indicates days in culture
2 cKO mice.
ampening of mPER2::LUC bioluminescence rhythms from WT (gray), VGAT-
a change. n = 6–12 per genotype.
negative control (NC) or grk2 siRNA.
condition per experiment. Experiment was performed three times with similar
2fl/+ (M), or versus NC siRNA (P). See also Figure S2.
rs
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the SCN of grk2 cKO mice throughout the circadian cycle may
reflect a compensatory change in the VIP-VPAC2 system in
response to increased receptor abundance (Figures S3E and
S3F). The effects of GRK2 are not generalized to all GPCRs,
since we found no substantial change in the abundance of V1a
receptors (the dominant AVP receptor subtype in the SCN) (Fig-
ure 3G) or AVP (Figures S3E and S3G) in the mutant SCN.
Collectively, our data suggest that GRK2 regulates ligand-
induced internalization of VPAC2 and PAC1 receptors. In the
absence of GRK2, total VPAC2 levels are elevated in the SCN
along with a compensatory reduction in VIP.
GRK2 Regulates Light-Triggered ERK Activation and
mPeriod1 Gene Transcription
Next, we turned our attention to the effects of grk2 ablation on
PER protein abundance. To explain the changes at the protein
level, we focused on period gene transcription as a potential
mechanism.We started by examining the p44/p42mitogen-acti-
vated protein kinase (MAPK)/ERK pathway, which has been
shown to couple light to period gene transcriptional activation
and clock resetting within the SCN (Butcher et al., 2002; Dziema
et al., 2003; Antoun et al., 2012). In wild-type SCN, a brief light
pulse (LP: 80 lux, 15min) in the early (CT 15) and late (CT 22) sub-
jective night, but not mid subjective day (CT 6), induces robust
phospho-activation of ERK1/2 (pERK1/2) relative to dark-treated
(DD) controls (Figures 4A and 4B). ERK1/2 activation in response
to early and late night light exposure was further augmented in
the SCN of grk2 cKO mice (Figures 4A and 4B). These data are
consistent with the notion that elevated ERK activation underlies
the exaggerated phase delays observed in grk2 cKOmice. How-
ever, a similar enhancement in pERK induction in the late night is
not sufficient for promoting phase advances in these animals;
additional molecular events specific to the late night may be
required in conjunction with ERK activation to mediate phase
advances.
We then investigated the effects of GRK2 on Per1 gene tran-
scription using a bacterial artificial chromosome (BAC) trans-
genic mousemodel that expresses destabilized, nuclear VENUS
fluorescent protein under the control of themPer1 gene (mPer1-
VENUS) (Cheng et al., 2009). This strain was bred onto a grk2+/
background. A CT 15 LP not only evoked greater ERK activation
in the SCN of grk2+/ mice compared with WT (Figures S4A and
S4B) but also resulted in a magnified fold-induction of mPer1-Figure 3. GRK2 Regulates GPCR Internalization In Vitro and VPAC2 Ab
(A–D) Representative micrographs illustrating the effects of overexpressing or sile
transfectedwith constructs encoding (A andB) GFP-tagged VPAC2 and (C) YFP-ta
K220R, or (B) NC or grk2 siRNA. Cells were either stimulated (+) or not stimulated
receptor internalization by indirect IF using a GFP/YFP-specific antibody. Recept
plasma membrane-localized receptors (yellow arrowheads). For (B), cells were s
fluorescence at the plasma membrane (PM) indicates no/little internalization, wh
substantial internalization. Values represent mean ± SEM% VPAC2-GFP cells th
NC siRNA; ##p < 0.01, ###p < 0.001 versus basal. (D) Same as (A) and (C), except th
PACAP for 20 min, and localization of receptors (green) was determined by direc
(E) Representative micrographs of VPAC2-IR in the SCN of WT and grk2 cKO m
(F) VPAC2-IR intensity in the SCN. Values represent mean ± SEM grayscale inte
(G) WB analysis of AVP V1a receptor (AVPR1A) expression in the SCN of WT and g
differences in GRK2 levels in grk2 cKO SCN samples may be due to incomplete
See also Figure S3.
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quence of both lower basal (DD) levels at CT 19 and higher
expression following the LP (Figures 4C and 4E). In contrast,
mPer1-VENUS induction following a CT 22 LP was comparable
between WT and grk2+/ mice (Figures S4C and S4D). Impor-
tantly, circadian rhythms of mPer1 transcription were also
altered in the SCN of grk2+/ mice, which displayed heightened
amplitude of mPer1-VENUS oscillations resulting from elevated
peak expression at CT 10 and suppressed trough expression
at CT 19 (Figures 4D and 4F). The effects of GRK2 on light-
induced and circadian transcription of mPer1 were confirmed
using qRT-PCR to compare levels of endogenous mPer1 tran-
scripts in the SCN of WT and grk2 cKO mice (Figure S4E). In
contrast, we found no effect of grk2 ablation on mPer2 at the
transcriptional level (Figure S4F).
ThemodulatoryeffectsofGRK2onmPer1 transcriptionmay rely
onkey signaling systems. InPAC1-GFP-expressingHEK293cells,
mPer1 promoter-driven luciferase (luc) reporter activity was
robustly induced by PACAP stimulation (Figure 4G). Overexpres-
sion of GRK2 abolished PACAP-triggered induction ofmPer1-luc
(Figure 4G). Conversely, grk2 siRNA-mediated silencing not only
enhanced PACAP-induced mPer1-luc activity but also elevated
basal activity (Figure 4H). U0126, a MEK1/2 inhibitor that
blocks ERK1/2 activation, abrogated the effects of grk2 silencing
on basal mPer1-luc and suppressed PACAP-induced mPer1-luc
activation to the same extent in both grk2 siRNA- and NC siRNA-
transfected cultures (Figure 4H). H89, a selective inhibitor of
cAMP-dependent protein kinase (PKA), which can feed into the
ERK1/2 pathway, abolished the increase in both basal and
PACAP-induced mPer1-luc activity in grk2-silenced cultures
without having a marked effect on NC cultures (Figure 4H).
Our data suggest that GRK2 negativelymodulatesmPer1 tran-
scription through an ERK1/2- and PKA-dependent mechanism,
and this transcriptional effect contributes to the higher-amplitude
PER1 protein rhythms observed in the SCN of grk2 cKOmice. On
the other hand, GRK2 does not influencemPer2 transcription per
se, but it may regulate PER2 at the post-transcriptional (or post-
translational) level to impact its protein expression.
GRK2 Regulates the Nuclear Localization of PER
Proteins
Most clock proteins are under post-translational regulation,
which dictates their stability and nuclear trafficking (Ko et al.,undance in the SCN In Vivo
ncing GRK2 on ligand-induced GPCR internalization. (A–C) Neuro2A cells were
gged V1b receptors alongwith (A andC) pcDNA empty vector, GRK2, or GRK2
(-, basal) with (A and B) VIP or (C) AVP, and harvested 20 min later to assess
ors (green); GRK2 (red); DAPI (blue). Internalized receptors (white arrowheads);
cored for degree of receptor internalization: a continuous line of VPAC2-GFP
ereas punctate (or a discontinuous line of) fluorescence at the PM indicates
at show continuous or punctate GFP fluorescence at the PM. *p < 0.05 versus
at the PAC1-GFP HEK293 stable cell line was used. Cells were stimulated with
t GFP fluorescence. Red indicates GRK2.
ice as a function of CT.
nsity. n = 4 mice per genotype per CT. **p < 0.01, ***p < 0.001 versus WT.
rk2 cKOmice as a function of CT. Actin was used as the loading control. Slight
Cre-mediated excision in individual animals.
rs
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2010; Chiu et al., 2008). The shortened PER2::LUC rhythms
in grk2 cKO SCN suggested to us that nuclear trafficking of
PER proteins may be facilitated in the absence of GRK2. In line
with this hypothesis, the nuclear localization of V5-tagged
PER1 (Figures 5A and 5E) and PER2 (Figures 5B and 5F) in
Neuro2A cells was significantly suppressed by overexpression
of GRK2. Expression intensity of V5-PER1 (Figure 5I) and V5-
PER2 (Figure 5J) was suppressed in the nucleus and elevated
in the cytoplasm of GRK2-overexpressed cells compared with
pcDNA3.1-transfected control cells. These effects of GRK2
overexpression were specific to PER1 and PER2 and were not
observed with V5-CRY1 (Figures S5A–S5C), V5-CRY2 (Figures
5C, 5G, and 5K), or myc-BMAL1 (Figures 5D, 5H, and 5L). In
the reciprocal experiment, grk2 siRNA-mediated knockdown
resulted in a significant reduction in cytoplasmic localization of
V5-PER2 and promoted its redistribution to the nucleus (Fig-
ure 5M). grk2 siRNA did not further promote the nuclear localiza-
tion of V5-PER1, which was already highly enriched in the nuclei
of NC siRNA-transfected Neuro2A cells (Figures S5D and S5E).
However, when we examined the nucleocytoplasmic expression
of endogenous PER1 in 4-day-old dispersed SCN neuronal
cultures, the distribution in GABAergic neurons was shifted
toward higher nuclear enrichment of PER1 in grk2 cKO cultures
compared with WT cultures (Figure 5N). Lastly, we quantified the
intensities of nuclear and cytoplasmic PER1 and PER2 expres-
sion in the intact SCN during the rising phase of their protein
rhythms, at CT 12 and CT 15, respectively. The results show
that PER1 (Figure 5O) and PER2 (Figure 5P) intensities in the nu-
cleus and cytoplasm were elevated in grk2 cKO SCN relative to
WT SCN. The overall increase in cellular PER in the mutant back-
ground may be attributed to enhanced transcription (in the case
ofmPer1) or enhanced protein stability (potentially in the case of
PER2). The cumulative evidence suggests that GRK2 sup-
presses nuclear trafficking of PER1 and PER2, delaying their
accumulation in the nucleus.
GRK2 Functionally Converges with Other Protein
Kinases to Regulate Nuclear Trafficking of PER Proteins
Nuclear translocation of PER proteins depend on their phos-
phorylation by specific protein kinases, including casein kinases
I delta and epsilon (CK1d and CK1ε) (Meng et al., 2010) and
glycogen synthase kinase 3b (GSK3b) (Iitaka et al., 2005). To
address potential functional interplay between GRK2 and otherFigure 4. Loss of GRK2 Enhances ERK Activation and Period1 Gene T
(A) Representative micrographs of pERK1/2 expression in the SCN of WT and g
harvested 30 min after LP onset. Dark controls (DD) were killed at the same time
(B) pERK1/2 intensity in the shell SCN at CT 6, and in the core SCN at CT 15 and
(C and D) Representative micrographs of VENUS-IR in the SCN of WT and gr
administered at CT 15 or (D) as a function of CT. In (C), DD controls were harves
(E and F) Venus-IR intensity (E) in the core SCN 4 hr after a CT 15 LP or (F) in the
fluorescence intensity. *p < 0.05, **p < 0.01, ***p < 0.001 versus WT. ##p < 0.01,
(G) Overexpression of GRK2 inhibits PACAP-inducedmPer1-luciferase activity in
firefly luciferase and constitutively expressed Renilla luciferase (Rluc) constructs, a
6 hr, or were unstimulated, and luciferase activity was measured. Values represe
(H) siRNA-mediated grk2 knockdown enhancesmPer1-luciferase activity in vitro i
transfected with NC or grk2 siRNA. Following a 30 min pre-treatment with U0126
inhibitor. Unstimulated cells were treated with DMSO vehicle (basal), U0126 or H
##p < 0.01, ###p < 0.001 versus no stim (G), basal (H), and PACAP alone (H). See
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we determined whether GRK2-dependent suppression of V5-
PER1/2 nuclear accumulation was sensitive to pharmacological
inhibition of other kinase pathways. Cytoplasmic retention of V5-
PER1 through GRK2 overexpression was partially blocked by
pre-treatment with the CK1d/ε inhibitor PF-670462 (Figures
6A–6C). Pharmacological inhibition of GSK3b, MEK1/2, and
PKA using LiCl, U0126, and H89, respectively, had no effect on
nuclear-cytoplasmic localization of V5-PER1 in either GRK2- or
pcDNA3.1-transfected cultures (Figures S6A, S6B, S6D, and
S6E). However, U0126 significantly increased V5-PER1 abun-
dance in the cytoplasm of GRK2 transfected cells (Figure S6C),
whereas H89 suppressed V5-PER1 abundance in the nucleus
of pcDNA3.1 transfected cells (Figure S6F), potentially through
mechanisms that impact protein stability.
In terms of PER2 trafficking, PF-670462 effectively eliminated
the difference in nuclear-cytoplasmic distribution of V5-PER2
between grk2 siRNA- and NC siRNA-transfected cultures by
decreasing the pool of cells that expressed V5-PER2 exclusively
in the cytoplasm (Figures 6D and 6E). H89 hadmodest effects on
the distribution of V5-PER2, whereas U0126 promoted cyto-
plasmic retention only upon grk2 knockdown (Figures 6F and
6G). In keeping with a well-documented role of GSK3b in PER2
localization (Iitaka et al., 2005), LiCl triggered robust cytoplasmic
retention in both grk2 siRNA- andNC siRNA-transfected cultures
(Figures 6F and 6G).
CK1d/ε inhibition evoked similar effects on GRK2-dependent
V5-PER1 and V5-PER2 subcellular localization in vitro. To
examine the in vivo effects of CK1d/ε blockade, we injected
WT and grk2 cKO mice with PF-670462 6 hr prior to SCN tissue
harvest for immunodetection of PER1 and PER2 at CT 14 and CT
18, respectively. Single-cell analysis revealed the expected in-
crease in number of cells expressing high nuclear levels of
PER1 and PER2 in the SCN of vehicle-injected grk2 CKO mice
compared with vehicle-treated WT controls (Figures 6H and
6I). This phenotypic difference between WT and grk2 cKO
micewas abolished by PF-670462 pre-treatment, which strongly
increased PER1 and PER2 nuclear expression in WT mice but
had a more modest effect in grk2 cKO mice (Figures 6H and
6I). Similar effects of PF-670462 on PER1 localization were
observed in grk2+/ mice and WT controls (Figures S6G and
S6H). Using the mPer1-VENUS transgene on a grk2+/ back-
ground, we further showed that the effects of PF-670462 areranscription in the SCN
rk2 cKO mice following a 15 min LP at CT 6, CT 15, or CT 22. Tissues were
.
CT 22.
k2+/ mice carrying the mPer1-VENUS transgene (C) 4 hr after a 15 min LP
ted at CT 19.
whole SCN as a function of CT. All values represent mean ± SEM grayscale/
###p < 0.001 versus DD.
vitro. PAC1-GFP HEK293 cells were transfected withmPer1 promoter-driven
long with GRK2 or pcDNA empty vector. Cells were stimulated with PACAP for
nt mean ± SEM normalized to Rluc activity.
n a MEK1/2- and PKA-dependent manner. Same as (G), except that cells were
or H89, cells were stimulated for 6 hr with PACAP in the presence of the kinase
89 for 6.5 hr. *p < 0.05, **p < 0.01, ***p < 0.001 versus pcDNA or NC siRNA.
also Figure S4.
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Figure 5. GRK2 Promotes Cytoplasmic Retention and Inhibits Nuclear Accumulation of PER1 and PER2 Proteins
(A–D) Neuro2A cells were transfected with (A) V5-PER1, (B) V5-PER2, (C) V5-CRY2, and (D) myc-BMAL1 (red) along with GRK2 (green) or pcDNA empty vector.
(E–H) Percentage of cells expressing (E) V5-PER1, (F) V5-PER2, (G) V5-CRY2, and (H) myc-BMAL1 in the nucleus only (red) or in both the nucleus and cytoplasm
(white).
(legend continued on next page)
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not dependent on changes in mPer1 transcription (Figures S6I
and S6J). Collectively, our data suggest that GRK2 acts coordi-
nately with CK1d/ε and other protein kinases to control nuclear-
cytoplasmic trafficking of PER1 and PER2.
GRK2 Physically Interacts with PER Proteins and
Promotes Phosphorylation of Ser545 on PER2
Our pharmacological results suggest that several protein ki-
nases, including GRK2, CK1d/ε, GSK3b, and others, coordi-
nately regulate PER1/2 levels in the nucleus and cytoplasm.
However, whether GRK2 directly regulates PER1/2 or indirectly
regulates them through these other (potential downstream) ki-
nases remains unclear. To address this issue, we probed for
protein-protein interactions between GRK2 and V5-PER1/2 us-
ing co-immunoprecipitation (coIP). Immunoprecipitation (IP) of
FLAG-tagged GRK2 was effective at pulling down V5-PER1
and V5-PER2 (Figure 7A). The reciprocal IP using V5 antibodies
also detected a physical association between V5-PER1/2 and
GRK2 in total and cytoplasmic protein extracts (Figure 7B). On
the other hand, we were unable to coIP GRK2 with FLAG-
CK1d, and vice versa, using YFP-tagged (Figure 7C) and un-
tagged (Figure S7) versions of GRK2.
To test whether GRK2 influences the phosphorylation of PER
proteins, we used mass spectrometry to identify residues in V5-
tagged murine PER2 that may be differentially phosphorylated
upon GRK2 overexpression in Neuro2A cells. Three PER2 phos-
phosites were identified by MS analysis of the V5 IP fraction:
Ser544, Ser545, and Ser624 (Figure 7D). TheMS peak intensities
for Ser544 and Ser624 fell below the threshold for accurate
quantitation. However, Ser545 phosphorylation met the criteria
for high confidence quantitation. Compared with pcDNA3.1 con-
trols, overexpression of wild-type GRK2 significantly enhanced
Ser545 phosphorylation (Figure 7E). This effect was dependent
on the kinase activity of GRK2, and was not observed with
GRK2 K220R overexpression (Figure 7E). Furthermore, PF-
670462 pre-treatment had no effect on the GRK2-dependent in-
crease in levels of phospho-Ser545 (Figure 7E), indicating that
GRK2 mediates Ser545 phosphorylation in a CK1d/ε-indepen-
dent manner. Our collective data suggest that GRK2 can physi-
cally bind to PER1 and PER2 and promote the phosphorylation
of PER2 at Ser545.
DISCUSSION
In this study, we show that GRK2 suppresses Per1 transcription
and nuclear accumulation of PER1/2 in the murine SCN. Conse-
quently, grk2 cKO mice exhibit higher amplitude of PER1/2 pro-(I–L) Mean intensity of (I) V5-PER1, (J) V5-PER2, (K) V5-CRY2, and (L) myc-BMA
(M) Neuro2A cells were transfected with V5-PER2 (green) and nuclear localized Ds
PER2+/DsRED+ cells that express V5-PER2 in the nucleus only (red), cytoplasm
(N) Relative nucleocytoplasmic distribution of endogenous PER1 in cultured prima
immunostained for PER1 (red) and GAD67 (green). Yellow arrowhead indicates a
bution was calculated by subtracting the cytoplasmic PER1-IR intensity from the
line graph for grk2 cKO SCN neurons is shifted toward more positive values rela
(O and P) Levels of (O) nuclear PER1 (red) at CT 12 and (P) nuclear PER2 (red) at C
expression. Phospho-PKC (green) was used to delineate the plasma membrane
cytoplasm. All values represent mean ± SEM from three independent experimen
*p < 0.05, **p < 0.01, ***p < 0.001 versus pcDNA (E–L), NC siRNA (M), or WT (O
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period, and aberrant entrainment to light. Our data further
indicate that GRK2 is a binding partner of PER1 and PER2, pro-
moting the phosphorylation of PER2 at Ser545. These findings
identify a key role of GRK2 in the transcriptional and post-trans-
lational modulation of the SCN circadian clock.
Two entrainment modalities—delays and advances—are
differentially affected by the downregulation of GRK2. Light-
induced behavioral phase delays are potentiated in grk2+/
and grk2 cKO mice, whereas LD entrainment by advances is
decelerated in both grk2 mutant strains. Acute advances are
dependent on grk2 gene dosage and are attenuated only in
grk2 cKO mice. The phenotypic similarities between grk2+/
and grk2 cKO mice suggest a threshold effect of GRK2 in
some, but not all, aspects of clock function/activity. This is not
altogether surprising given that reducing GRK2 levels by 50%
(using grk2+/ mice) is sufficient to evoke strong phenotypes in
various tissues (Vila-Bedmar et al., 2012). Paradoxically, the
opposing effects of GRK2 on late-night advances and early-
night delays are accompanied by similar elevation of light-
induced ERK activation. Previous studies have shown that
ERK activation is required for both phase delays and advances
(Butcher et al., 2002). However, other signal transduction path-
ways such as ryanodine receptors and guanylyl cyclase (GC)
are phase restricted in their activation, and mediate delays and
advances, respectively (Ding et al., 1998; Tischkau et al.,
2003). Despite the increase in late-night ERK activation, which
should promote, rather than suppress, advances in the grk2
cKO mice, it is possible that grk2 ablation disrupts or attenuates
GC signaling, overriding the expected effects of ERK. Alterna-
tively, increased ERK activation in the grk2 cKO SCN in the
late night may be aberrantly promoting delay-specific signaling
pathways ‘‘at the wrong time of day.’’
Our findings also reveal that GRK2 depletion heightens the
amplitude of circadian oscillations in the SCN. PER2::LUC
rhythms are higher in grk2 cKO SCN explants, and peak abun-
dance of PER1 and PER2 was similarly enhanced in the SCN
of mutant mice. The amplitude increase is not the consequence
of greater interneuronal synchrony within the SCN, as there was
no alteration in the dampening of PER2::LUC rhythms ex vivo.
Enhanced circadian oscillator amplitude, but not interneuronal
coupling, may therefore be a contributing factor to the slower
rate of LD re-entrainment observed in grk2-deficient mice. The
changes in the VIP-VPAC2 system of grk2 cKO mice are consis-
tent with the lack of a synchrony phenotype: the increase in
VPAC2 levels in the SCN, which is predicted to improve syn-
chrony, is offset by reduced abundance of VIP. On the otherL1 expression in the nucleus (red) and cytoplasm (black).
RED (DsRED-nuc) (red), along with NC or grk2 siRNA. Graph represents% V5-
only (white), or nucleus and cytoplasm (blue).
ry GABAergic SCN neurons harvested fromWT and grk2 cKOmice. Cells were
cell with predominantly nuclear expression of PER1. Relative intensity distri-
nuclear intensity. Positive values on the x axis indicate nuclear enrichment. The
tive to WT.
T 15 are enhanced in SCN neurons of grk2 cKOmice at the upswing of PER1/2
and cytoplasm. Graphs show PER1- or PER2-IR intensity in the nucleus and
ts.
and P). See also Figure S5.
rs
(legend on next page)
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hand, the shortening of PER2::LUC rhythms is consistent with
the amplitude enhancement, particularly in light of the fact
that nuclear PER1/2 levels are greater during the upswing of
their rhythms. The divergent effects of grk2 ablation on behav-
ioral and SCN rhythms suggest that the longer behavioral
period of grk2 cKO mice is not driven by the SCN alone, but
rather by interactions between the SCN and extra-SCN
oscillators, or between the SCN and its inputs, regardless of
whether or not they (i.e., extra-SCN oscillators and inputs) ex-
press GRK2. Interestingly, an inverse relationship between
behavioral and Per1-luc SCN rhythms has also been previously
observed, but within the context of non-24-hr light cycles (Aton
et al., 2004).
Is it possible that the behavioral phenotypes of grk2-deficient
mice are the result of dysfunction in retinal inputs rather than the
SCN oscillator itself? The fact that GRK2 is also expressed in
retinal ganglion cells and regulates melanopsin signaling (Blasic
et al., 2012)may, in principle, make it difficult to conclude that the
phenotypes are mediated at the level of the SCN. However, our
GABAergic neuron-specific cKO model should not ablate grk2
expression in melanopsin cells, which are intrinsically glutama-
tergic. Moreover, by isolating the SCN and abolishing afferent in-
puts, the SCN explant model supports a direct function of GRK2
within the SCN.
What are the underlying mechanisms for the amplitude in-
crease in PER expression in the SCN? Transcriptional regulation
of mPer1 is one causative factor. By reducing grk2 levels in the
SCN, both circadian and light-evoked expression of mPer1 is
enhanced. However, the effects of GRK2 downregulation are
specific to mPer1 and do not extend to mPer2 expression.
mPer1-luc reporter assays in cell culture further showed that
the facilitatory effects of grk2 knockdown on basal and
PACAP-induced transcription of mPer1 relied on ERK1/2 and
PKA activation. The aggregate evidence suggests that GRK2
suppresses mPer1 transcription through a CRE-dependent
mechanism, which is activated downstream of ERK1/2 and
PKA. cAMP-dependent signaling has been shown to sustain
the transcriptional feedback loops of the SCN pacemaker, influ-
encing period and amplitude (O’Neill et al., 2008). Although the
promoters of mPer1 and mPer2 both contain a canonical CRE
element within 2 kb of the transcription start site, only the
mPer1 promoter is sensitive to agents that normally trigger
CRE-mediated transcription; themPer2 promoter is functionally
unresponsive despite the ability of CREB to bind to its CRE site
(Travnickova-Bendova et al., 2002). On the other hand, given the
invariant levels of mPer2 transcript between mutant and controlFigure 6. GRK2 Functionally Converges with CK1d/ε and Other Prom
Distribution of PER1 and PER2
(A, D, and F) Neuro2A cells were transfected with (A) V5-PER1 (red) along with GR
with NC or grk2 siRNA. Cells were either mock-treated (basal) or treated for 4 hr
(B, E, and G) Percentage of (B) V5-PER1+ or (E and G) V5-PER2+/DsRED+ cells
cytoplasm (white), or (E and G) express V5-PER2 in the nucleus only (red), cytopla
nucleus (red) and cytoplasm (black). Values represent mean ± SEM from three in
(H and I) Nuclear accumulation of PER1 and PER2 in the SCNof grk2 cKOmice is le
PER2 at CT 18 in the SCN ofWT and grk2 cKOmice pretreated with vehicle or PF-
and (I) PER2 at CT 18. Cells that exceeded a given expression threshold are cou
***p < 0.001 versus pcDNA. #p < 0.05, ##p < 0.01, ###p < 0.001 versus basal.
See also Figure S6.
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due to enhancement in translation, protein stability, or both.
Period determination depends on the timing and extent of nu-
clear accumulation of PER and CRY proteins (Tamanini et al.,
2005). The period effects of grk2 ablation may be explained
by a role of GRK2 in the nuclear trafficking of PER1/2 pro-
teins. GRK2 overexpression promotes cytoplasmic retention of
mPER1 and mPER2, whereas grk2 knockdown has the opposite
effect on mPER2 localization. The use of ectopic mPER1 and
mPER2 sidesteps confounding factors related to endogenous
transcription and translation, although it does not eliminate the
influence of altered protein stability. Despite the fact that
GRK2-dependent PER1/2 cytoplasmic retention was sensitive
to CK1d/ε inhibition in vitro and in vivo, we hesitated to conclude
that GRK2 regulates PER1/2 localization specifically through
CK1d/ε as the downstream effector, for two reasons. First,
in vitro inhibition of two other kinase pathways, GSK3b and
ERK1/2, also had modulatory effects on grk2 siRNA-dependent
PER2 localization. Second, because GRK2 does not physically
interact with CK1d, it becomes difficult to envision a scenario
whereby GRK2 can directly regulate the activity of CK1d on
PER proteins. A plausible explanation for our findings is that
PER1/2 localization is dictated by the balance of activities
among multiple kinase signaling pathways that converge on
PER. The effects of certain kinases may be dominant over others
(e.g., CK1d/ε). However, as this study reveals, GRK2 is one ki-
nase pathway that also contributes to the modulation of PER
localization.
How might GRK2 affect the behavior of PER1 and PER2? The
physical association between GRK2 and PER1/2 not only sug-
gests a direct mode of regulation but also reveals a potential
noncanonical function of GRK2. Importantly, GRK2 promotes
the phosphorylation of PER2 on Ser545 in a manner dependent
on its kinase activity. This residue is phosphorylated by CK1d
in vitro and by endogenous kinases in HEK293 cells (Vanselow
et al., 2006). However, GRK2-dependent mPER2 Ser545 phos-
phorylation was not blocked by PF-670462, suggesting that
GRK2 either directly phosphorylates this residue or induces its
phosphorylation by a kinase other than CK1d/ε. Two possible
mechanisms may underlie GRK20s ability to sequester PER1/2
in the cytoplasm. First, GRK2—or a downstream kinase whose
activity is induced by GRK2—phosphorylates PER2 at Ser545
to trigger its cytoplasmic retention. Second, GRK2 acts as a
scaffold protein to physically retain PER2 (and PER1) in the cyto-
plasm in a kinase-independent manner. The Ser-545 residue is
not conserved in human PER2, suggesting that the scaffoldinent Protein Kinase Pathways to Regulate the Nucleocytoplasmic
K2 (green) or pcDNA, or (D and F) V5-PER2 (green) and DsRED-nuc (red) along
with (A and D) PF-670462 or (F) H89, LiCl or U0126.
that (B) express V5-PER1 in the nucleus only (red) or in both the nucleus and
sm only (white), or both (blue). (C) Mean intensity of V5-PER1 expression in the
dependent experiments.
ss sensitive to the effects of PF-670462. Expression of (H) PER1 at CT 14 and (I)
670462 6 hr earlier. Histograms show intensity distribution of (H) PER1 at CT 14
nted. Low threshold values indicate strong expression. *p < 0.05, **p < 0.01,
rs
Figure 7. GRK2 Physically Interacts with PER1 and PER2 and Promotes Phosphorylation of PER2 at Ser545
(A and B) Neuro2A cells were transfected with V5-PER1 or V5-PER2 along with FLAG-GRK2 or pcDNA3.1 empty vector. Extracted proteins from total cell lysates
or the cytoplasmic fraction were immunoprecipitated (IP) with (A) aFLAG or (B) aV5 antibody-conjugated agarose beads and immunoblotted (IB) with both
antibodies.
(C) GRK2 does not physically interact with CK1d. Neuro2A cells were transfectedwith GRK2-YFP, FLAG-CK1d, CMV-GFP (GFP only), or pcDNA3.1 empty vector.
IP was performed on total protein lysates using aFLAG or aGFP antibody-conjugated agarose beads and IB with both antibodies.
(D) mPER2 phosphosites identified in our MS experiment. Phosphorylated residue in parentheses.
(E) GRK2 overexpression increases phosphorylation of PER2 at Ser545. Neuro2A cells were transfected with V5-PER2 and either FLAG-GRK2 (wild-type), GRK2
K220R, or pcDNA3.1 empty vector. Cells were treated with PF-670462 or vehicle 4 hr prior to harvesting. IP was performed using aV5 antibody-conjugated
beads, and eluates were resolved by SDS-PAGE followed by in-gel digestion prior to MS analysis. Values are given as quantified MS intensity units. Each color
represents a biological replicate (n = 3 per condition).
(legend continued on next page)
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role of GRK2may bemore pertinent. On the other hand, a greater
number of phosphosites have been documented for mPER2
compared with hPER2 (53 versus 15, with 6 overlapping sites;
http://www.phosphosite.org), suggesting that theremay be spe-
cies-specific differences in the phosphoregulation of PER2 ac-
tivity, which in turn might influence interspecies variations in
circadian period. The multiple phosphorylation sites on PER is
consistent with observations that multiple protein kinases
interact synergistically in a temporal order to regulate PER local-
ization through daily changes in phospho-occupancy (Chiu et al.,
2008; Ko et al., 2010).
Figure 7F integrates our findings into a hypothetical model of
GRK2 function in the SCN. We propose that GRK2 dampens
ERK1/2-dependentmPer1 transcription, through potential mod-
ulation of GPCR signaling. In addition, GRK2 acts post-transla-
tionally on PER1 and PER2, physically binding to both proteins
and promoting the phosphorylation of PER2. We believe that it
is through this second, nonclassical pathway that GRK2 modu-
lates the trafficking of PER proteins into the nucleus. Whether
or not the physical association with, or phosphorylation of,
PER also impacts the stability of PER proteins remains a subject
for future investigation.
EXPERIMENTAL PROCEDURES
Animals
Grk2+/ (Adrbk1tm1Mca; Jaber et al., 1996), grk2fl/fl (Adrbk1tm1Gwd; Matkovich
et al., 2006), Vgat-IRES-Cre knockin (Slc32a1tm2(cre)Lowl; Vong et al., 2011),
mPER2::LUC (Yoo et al., 2004), and Period1::VENUS transgenic (Cheng
et al., 2009) mouse strains were used in this study. Animal experiments were
conducted at the University of Toronto Mississauga animal facility and
approved by the local animal care committee in compliance with institutional
guidelines and the Canadian Council on Animal Care.
Behavior
Youngmalemicewere housed in running-wheel cages placedwithin light-tight
circadian activity chambers under computer-controlled lighting schedules
(Phenome Technologies). For the jetlag paradigm, mice were entrained to a
12-hr light:12-hr dark (LD) cycle before being transferred abruptly to a 7-hr
advanced 12:12 LD cycle. For phase-shift experiments, LD-entrained mice
were released into constant darkness (DD) for 2 weeks prior to receiving a brief
(15 min) light pulse (LP) at circadian time (CT) 15 (30 lux) or CT 22 (40 lux). For
constant light (LL) experiments, LD-entrained mice were released into con-
stant dim light (10 lux) for 16 weeks. Behavioral analyses were performed
with the ClockLab software (Actimetrics). Period was determined by c2 perio-
dogram analysis. Phase shifts were defined as the displacement between two
regression lines that were software-fitted through the daily activity onsets
10 days before and 10 days after an LP.
Light Treatment and Tissue Harvest and Processing
Mice were dark-adapted for 2 days prior to further treatment and tissue har-
vest. For LP experiments, mice received a 15 min LP (80 lux) at the indicated
CT and were killed by cervical dislocation at designated times. For in vivo
CK1d/ε inhibition, mice received an intraperitoneal injection of PF-670462
(30 mg/kg) or saline at CT 8 or CT 12 prior to tissue harvest 6 hr later. Coronal
SCN tissues were harvested using a vibratome as reported previously (Antoun(F) A proposed model of GRK2-mediated regulation ofmPeriod1 gene transcriptio
pathway in a G-protein-dependent manner, leading to phospho-activation of CR
through GPCR downregulation. GRK2 also promotes the phosphorylation of PER
PER2. A, receptor agonist; B, BMAL1; C, CLOCK; G, heterotrimeric G protein; P
See also Figure S7.
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(4% paraformaldehyde [PFA] in PBS [pH 7.4]), cryoprotected (30% sucrose in
PBS), and cut into 30-mm thin sections using a freezing microtome.
Cell Culture Experiments
Cells were transfected with Lipofectamine 3000 (Life Technologies). 18–24 hr
post-transfection, cells were stimulated or treated with pharmacological inhib-
itors for a prescribed length of time. Cells were either fixed in 4% PFA for sub-
sequent immunostaining, or lysates were prepared for WB or in vitro luciferase
assay.
Dispersed SCN Cell Culture
SCN tissues from 6-day-old Vgatcre/+::grk2fl/fl and grk2fl/fl pupswere dissected,
trypsin digested, triturated and plated onto poly-D-lysine-coated glass cover-
slips. Four days later, cells were fixed with 4% PFA for 20 min and stained for
GAD67 and mPERIOD1.
Co-immunoprecipitation
Transfected Neuro2A cells were lysed in lysis buffer supplemented with prote-
ase and phosphatase inhibitors. The enrichment of membrane/cytoplasmic
cell fractions was performed using published methods (http://www.abcam.
com/protocols/subcellular-fractionation-protocol). For the coIP, 0.5–1 mg
protein lysate was incubated overnight at 4C with one of the following: anti-
V5 agarose beads (Life Technologies), anti-FLAG M2-agarose beads
(Sigma-Aldrich), or 1–2 mg anti-GFP or anti-GRK2 antibody along with TrueBlot
anti-rabbit immunoglobulin IP Beads (Rockland Immunochemicals).
Western Blot Analysis
Proteins were separated by SDS-PAGE and immunoblotted for the desired
protein as described previously (Antoun et al., 2012).
Luciferase Assay
mPer1-driven firefly luciferase activity in transiently transfected PAC1-HOP1-
GFP cells was measured using the Dual Glo Luciferase Assay System
(Promega) and normalized to TK-driven Renilla luciferase activity.
Immunohistochemistry, Immunofluorescence, and
Immunocytochemistry
Tissue immunohistochemistry and immunofluorescence (IF) were performed
as described previously (Antoun et al., 2012). Immunocytochemistry of
cultured cells was performed in the same manner as tissue IF.
Imaging and Quantification
Images were acquired using a Zeiss Axio Observer Z1 inverted microscope
equipped with a Laser Scanning Microscope (LSM) 700 module (for confocal
image acquisition) and an AxioCam MRm Rev.3 monochromatic digital cam-
era (for acquisition of bright-field images, Zeiss), along with the ZEN 2010 soft-
ware. Images were analyzed using the ImageJ software. The polygon tool was
used to outline the region of interest. The ‘‘measure’’ function was used to
obtain a ‘‘mean gray’’ value for immunoreactive staining within the specified re-
gion. To obtain a normalized ‘‘mean gray’’ value, background ‘‘mean gray’’
values from surrounding non-immunoreactive regions (e.g., lateral hypothala-
mus) were subtracted from the intensity values. For PER1 and PER2 cell
counts across the 24-hr cycle, images were equally assigned aminimum gray-
scale threshold of 150 and 160, respectively. The ‘‘analyze particle’’ function
was then used to obtain an immunoreactive cell count.
Cultures and Bioluminescence Recordings
Using the Lumicycle-32 instrument (Actimetrics) and published methods (Ya-
mazaki and Takahashi, 2005), we recorded bioluminescence from 300-mmn and PER nuclear trafficking. Agonist-stimulated GPCRs activate the ERK1/2
EB and CRE-mediated transcription of mPeriod1. GRK2 inhibits this pathway
2, potentially through a direct mechanism, resulting in cytoplasmic retention of
, phosphorylation.
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coronal SCN slices from 10- to 15-day-old pups. Period and baseline-
subtracted counts were obtained with the Lumicycle Analysis software
(version 2.56, Actimetrics) to calculate amplitude and dampening of oscillatory
luciferase activity. For bioluminescence recording from immortalized homozy-
gous Per2Luc MEFs, cells were transfected with grk2 siRNA or NC siRNA,
and transferred to recording media 4 hr later. Bioluminescence was recorded
for 5–7 days.
Mass Spectrometry
Transfected Neuro2A cells (n = 3 biological replicates per condition) were
treated with PF-670462 (9 mM) or vehicle for 4 hr prior to harvesting. Cell ly-
sates were incubated with anti-V5 agarose beads (Life Technologies) at 4C
overnight. Eluted proteins were resolved by SDS-PAGE. Gel pieces (100–
250 kDa) were excised for in-gel digestion, and the resulting peptide mixtures
were analyzed by an LTQ Velos Pro Orbitrap Elite mass spectrometer (Thermo
Fisher Scientific) equippedwith a nano-electrospray interface (ekspert nanoLC
400 system) operated in positive ion mode. Separation of peptides was per-
formed on an analytical column (75 mm 3 10 cm) packed with reverse phase
beads. The instrument method consisted of one full MS scan from 400 to
2000 m/z followed by data-dependent MS/MS scan of the 20 most intense
ions, a dynamic exclusion repeat count of 2, and a repeat duration of 90 s.
The full mass was scanned in an Orbitrap analyzer with R = 60,000 (defined
at m/z 400), and the subsequent MS/MS analyses were performed in LTQ
analyzer.
Protein identification was analyzed with MaxQuant (Version 1.3.0.5) using
Andromeda as a search engine against the UniProt (release 2013_05) data-
base restricted to Mouse (Mus musculus) taxonomy concatenated with a
decoy reversed sequences. Spectral counts-based quantitation was carried
out using the intensity information in Phospho (STY)Sites file.
Statistical Analyses
One- and two-way analyses of variance (ANOVA) were used to analyze
data. Post hoc significance of pairwise comparisons was assessed using
Fisher’s least significant difference (LSD) tests with a set at 0.05. Statistical
analyses were carried out with StatPlus:mac LE (AnalystSoft; http://www.
analystsoft.com).
ACCESSION NUMBERS
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium and are available under accession number
PXD002290.
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